A phase II clinical trial of the Aurora and angiogenic...

Breast Cancer Research 2018 / 12 Vol. 20; Iss. 1

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Diamond, Jennifer R., Eckhardt, S. G., Pitts, Todd M., van Bokhoven, Adrie, Aisner, Dara, Gustafson, Daniel L., Capasso, Anna, Sams, Sharon, Kabos, Peter, Zolman, Kathryn, Colvin, Tiffany, Elias, Anth
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
20
Language:
english
Journal:
Breast Cancer Research
DOI:
10.1186/s13058-018-1014-y
Date:
December, 2018
File:
PDF, 1.28 MB
english, 2018
Conversion to is in progress
Conversion to is failed